Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Age-related dysregulation of intestinal epithelium fucosylation is linked to an increased risk of colon cancer
Zhihan Wang, Pan Gao, Kai Guo, Grace Schirrick, Jappreet Singh Gill, Jett Weis, Abby Lund Da Costa, Mansib Rahman, Het Mehta, Julia Fleecs, Shilpi Jain, Trishna Debnath, Junguk Hur, Nadeem Khan, Robert Sticca, Holly M. Brown-Borg, Donald A. Jurivich, Ramkumar Mathur
Zhihan Wang, Pan Gao, Kai Guo, Grace Schirrick, Jappreet Singh Gill, Jett Weis, Abby Lund Da Costa, Mansib Rahman, Het Mehta, Julia Fleecs, Shilpi Jain, Trishna Debnath, Junguk Hur, Nadeem Khan, Robert Sticca, Holly M. Brown-Borg, Donald A. Jurivich, Ramkumar Mathur
View: Text | PDF
Research Article Aging Microbiology

Age-related dysregulation of intestinal epithelium fucosylation is linked to an increased risk of colon cancer

  • Text
  • PDF
Abstract

Colon cancer affects people of all ages. However, its frequency, as well as the related morbidity and mortality, are high among older adults. The complex physiological changes in the aging gut substantially limit the development of cancer therapies. Here, we identify a potentially unique intestinal microenvironment that is linked with an increased risk of colon cancer in older adults. Our findings show that aging markedly influenced persistent fucosylation of the apical surfaces of intestinal epithelial cells, which resulted in a favorable environment for tumor growth. Furthermore, our findings shed light on the importance of the host-commensal interaction, which facilitates the dysregulation of fucosylation and promotes tumor growth as people get older. We analyzed colonic microbial populations at the species level to find changes associated with aging that could contribute to the development of colon cancer. Analysis of single-cell RNA-sequencing data from previous publications identified distinct epithelial cell subtypes involved in dysregulated fucosylation in older adults. Overall, our study provides compelling evidence that excessive fucosylation is associated with the development of colon cancer, that age-related changes increase vulnerability to colon cancer, and that a dysbiosis in microbial diversity and metabolic changes in the homeostasis of older mice dysregulate fucosylation levels with age.

Authors

Zhihan Wang, Pan Gao, Kai Guo, Grace Schirrick, Jappreet Singh Gill, Jett Weis, Abby Lund Da Costa, Mansib Rahman, Het Mehta, Julia Fleecs, Shilpi Jain, Trishna Debnath, Junguk Hur, Nadeem Khan, Robert Sticca, Holly M. Brown-Borg, Donald A. Jurivich, Ramkumar Mathur

×

Figure 7

Inhibition of fucosylation suppresses the expression of cancer-related genes and inhibits colon cancer cell migration and proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of fucosylation suppresses the expression of cancer-related g...
Human epithelial colon cancer DLD-1 cells were treated with DMSO (vehicle), 100 μM resveratrol (RSV), or 300 μM fucosylation inhibitor 2F-peracetyl-fucose (2FF) for 24 hours. (A) Reverse transcription quantitative PCR (qPCR) analysis for FUT2, FUT8, LGR5, PCNA, P53, and P21 in DLD-1 cells treated with RSV and 2FF. LGR5, leucine-rich repeat-containing G protein–coupled receptor 5; PCNA, proliferating cell nuclear antigen. (B–E) DLD-1 cell migration and proliferation inhibited by RSV and 2FF. (B) Typical images (left) and corresponding statistical results (right) of Transwell invasion and migration assays in DLD-1 cells treated with vehicle, RSV, and 2FF. Scale bar = 50 μm. (C) Representative images (left) and quantification (right) of wound healing assay at 0 and 24 hours in DLD-1 cells treated with vehicle, RSV, and 2FF. Light blue line marks scratch wound edges. Scale bar = 200 μm. Scratched areas were quantified as a percentage after 24 hours relative to 0 hours. (D) Representative images (left) and relative fraction (right) of EdU-positive cells. EdU, 5-ethynyl-2′-deoxyuridine. Scale bar = 50 μm. (E) Measurement of cell proliferation using CCK8 assays. CCK8, cell counting kit-8. All data represent means ± SD; n = 6 (A) and n = 4 (B–E). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by 1-way ANOVA. (F) Schematic of proposed mechanism illustrating how core fucosylation of IECs influences microbiota and may impact aging and cancer development.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts